PainReform Ltd.
PRFX · NASDAQ
Bulios Fair Price
$1.17
36.0% upside
Trenutna cena
$0.86
Po podatkih Bulios Fair Price je delnica PRFX trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
PainReform Ltd. (PRFX) is a biotechnology company focused on developing innovative therapeutics for pain management. Their main product is a local anesthetic-based medication called PRF-110, which is intended for the treatment of acute and chronic pain conditions. PainReform Ltd. focuses on leveraging its patented technologies to enhance the efficacy and durability of medicinal preparations, providing patients with effective and safe pain treatment options. The company also focuses on developing new drug formulations and therapeutic applications to improve the quality of life for patients suffering from various painful conditions. Shares of PainReform Ltd. (PRFX) could be suitable for investors who are tracking innovations in pain management and seeking investment opportunities in the biotechnology sector.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Efraim Cohen-Arazi
Employees
7
Headquarters
Tel Aviv